Dissection of the NF-κB signalling cascade in transgenic and knockout mice
暂无分享,去创建一个
[1] A. Hevener,et al. IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.
[2] S. Ley,et al. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. , 2004, The Biochemical journal.
[3] R. Bolli,et al. Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha. , 2001, Journal of molecular and cellular cardiology.
[4] I. Verma,et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. , 1999, Genes & development.
[5] Michael Karin,et al. NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.
[6] F. Yull,et al. Lymphocytes Lacking IκB-α Develop Normally, But Have Selective Defects in Proliferation and Function1 , 2000, The Journal of Immunology.
[7] S. Akira,et al. Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.
[8] Georg Kraal,et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.
[9] M. Karin,et al. An Essential Role for Nuclear Factor κB in Promoting Double Positive Thymocyte Apoptosis , 1999, The Journal of experimental medicine.
[10] G. Courtois,et al. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. , 2000, Molecular cell.
[11] R. Maehr,et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Israël,et al. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. , 2000, Genes & development.
[13] M. Boothby,et al. Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.
[14] H. Carlsen,et al. In Vivo Imaging of NF-κB Activity1 , 2002, The Journal of Immunology.
[15] R. Flavell,et al. Activation of NF-kappaB promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells. , 2005, International immunology.
[16] A. Israël,et al. Forebrain-Specific Neuronal Inhibition of Nuclear Factor-κB Activity Leads to Loss of Neuroprotection , 2003, The Journal of Neuroscience.
[17] M. Karin,et al. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion , 2003, Nature Medicine.
[18] Michael Karin,et al. IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.
[19] G. Courtois,et al. Mature T cells depend on signaling through the IKK complex. , 2003, Immunity.
[20] B. Dörken,et al. Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. , 2005, Immunity.
[21] M. T. Hasan,et al. IKK mediates ischemia-induced neuronal death , 2005, Nature Medicine.
[22] K. Rajewsky,et al. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. , 2004, The Journal of clinical investigation.
[23] Inder M. Verma,et al. Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .
[24] C. Jongeneel,et al. Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation. , 1998, Molecular immunology.
[25] R. Bravo,et al. Expression of Constitutively Active IκBβ in T Cells of Transgenic Mice: Persistent NF-κB Activity Is Required for T-Cell Immune Responses , 1998, Molecular and Cellular Biology.
[26] T. Luedde,et al. Deletion of IKK 2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia / reperfusion injury , 2005 .
[27] R. Gaynor,et al. I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function. , 2002, Journal of immunology.
[28] C. Tato,et al. Inhibition of NF-κB Activity in T and NK Cells Results in Defective Effector Cell Expansion and Production of IFN-γ Required for Resistance to Toxoplasma gondii1 , 2003, The Journal of Immunology.
[29] Steffen Jung,et al. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation , 2000, Nature Medicine.
[30] M. Karin,et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.
[31] T. Mak,et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.
[32] D. Goeddel,et al. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. , 1999, Immunity.
[33] Inder M Verma,et al. NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.
[34] D. Brenner,et al. Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super‐repressor , 1998 .
[35] H. Edlund,et al. Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion. , 2005, Diabetes.
[36] D. F. Barber,et al. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. , 2000, Immunity.
[37] M. Serra,et al. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.
[38] K. Rajewsky,et al. IκB Kinase Signaling Is Essential for Maintenance of Mature B Cells , 2002, The Journal of experimental medicine.
[39] Rune Blomhoff,et al. In vivo imaging of NF-kappa B activity. , 2002, Journal of immunology.
[40] J. Christman,et al. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. , 2000, American journal of respiratory and critical care medicine.
[41] J. Peschon,et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] N. Fausto,et al. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. , 2002, The Journal of clinical investigation.
[43] T. Leary,et al. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality , 1999 .
[44] E. Schmidt,et al. IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.
[45] V. Godfrey,et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.
[46] W. Frontera,et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.
[47] David Piwnica-Worms,et al. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.
[48] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.
[49] F. Weih,et al. Differential Requirement for Rel/Nuclear Factor κB Family Members in Natural Killer T Cell Development , 2003, The Journal of experimental medicine.
[50] M. Karin,et al. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. , 2004, Nature.
[51] M. Karin,et al. IKKalpha controls formation of the epidermis independently of NF-kappaB. , 2001, Nature.
[52] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[53] Richard A. Flavell,et al. Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000, The Journal of Biological Chemistry.
[54] F. Weih,et al. Inhibition of NF‐κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice , 2001, European journal of immunology.
[55] U. Siebenlist,et al. Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.
[56] S. Akira,et al. Iκb Kinase α Is Essential for Mature B Cell Development and Function , 2001, The Journal of experimental medicine.
[57] D. Brenner,et al. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. , 1998, Hepatology.
[58] E. Schmidt,et al. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. , 2001, Cell.
[59] R. Brink,et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.
[60] M. Karin,et al. IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. , 2003, Immunity.
[61] Keith W. Jones,et al. Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α , 2001 .
[62] M Aguet,et al. Inducible gene targeting in mice , 1995, Science.
[63] K. Rajewsky,et al. Conditional gene targeting. , 1996, The Journal of clinical investigation.
[64] U. Siebenlist,et al. Control of lymphocyte development by nuclear factor-kappaB. , 2005, Nature reviews. Immunology.
[65] P. Khavari,et al. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Tato,et al. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. , 2003, Journal of immunology.
[67] R. Gaynor,et al. I-κB Kinase β Is Critical for B Cell Proliferation and Antibody Response , 2002, The Journal of Immunology.
[68] N. Perkins. Oncogenes, tumor suppressors and p52 NF-κB , 2003, Oncogene.
[69] A. Hoffmann,et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. , 2005, Immunity.
[70] L. Ährlund‐Richter,et al. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. , 1999, Cancer research.
[71] N. Fausto. Liver regeneration. , 2000, Journal of hepatology.
[72] K. Rajewsky,et al. IκB Kinase 2 Deficiency in T Cells Leads to Defects in Priming, B Cell Help, Germinal Center Reactions, and Homeostatic Expansion1 , 2004, The Journal of Immunology.
[73] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.
[74] P. Khavari,et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .
[75] A. Strasser,et al. The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. , 2003, Seminars in immunology.
[76] M. Karin,et al. IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .
[77] C. Jongeneel,et al. Abnormal T lymphocyte development induced by targeted overexpression of IkappaB alpha. , 1997, Journal of immunology.
[78] T. Deerinck,et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. , 1999, Science.
[79] K. Akashi,et al. Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. , 2003, Immunity.
[80] R. Gaynor,et al. I-κB Kinases α and β Have Distinct Roles in Regulating Murine T Cell Function1 , 2002, The Journal of Immunology.
[81] E. Oltz,et al. An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets , 1999 .
[82] L. Moldawer,et al. LPS-induced liver injury ind-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor , 2000 .
[83] R. Sherwin,et al. Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. , 2000, The Journal of biological chemistry.
[84] David S. Park,et al. Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival , 2002, The Journal of Neuroscience.
[85] C. Irvin,et al. A Prominent Role for Airway Epithelial NF-κB Activation in Lipopolysaccharide-Induced Airway Inflammation1 , 2003, The Journal of Immunology.
[86] A. Hevener,et al. IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.
[87] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[88] M. Karin,et al. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis , 2004, Nature.
[89] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[90] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[91] W. Frontera,et al. IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.
[92] D. Brenner,et al. In Vivo Pattern of Lipopolysaccharide and Anti-CD3-Induced NF-κB Activation Using a Novel Gene-Targeted Enhanced GFP Reporter Gene Mouse1 , 2004, The Journal of Immunology.
[93] R. Kühn,et al. Cre/loxP recombination system and gene targeting. , 2002, Methods in molecular biology.
[94] M. Karin,et al. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. , 2001, Immunity.
[95] Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. , 2005, The Journal of clinical investigation.
[96] M. Kay,et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors , 1997, Journal of virology.
[97] A. Strasser,et al. The role of Rel/NF-κB transcription factors in B lymphocyte survival , 2003 .
[98] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[99] R. Bravo,et al. Functional Redundancy of the Nuclear Factor κB Inhibitors IκBα and IκBβ , 1998, The Journal of experimental medicine.
[100] I. Verma,et al. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. , 1999, Science.
[101] B. Ryffel,et al. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. , 2005, Immunity.
[102] H. Edlund,et al. Nuclear Factor-κB Activity in β-Cells Is Required for Glucose-Stimulated Insulin Secretion , 2005 .
[103] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[104] T. Deerinck,et al. Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .
[105] T. Wirth,et al. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation , 1993, Nature.
[106] M. Karin,et al. IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.
[107] G. Courtois,et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.
[108] M. Karin,et al. IKK beta is required for peripheral B cell survival and proliferation. , 2003, Journal of immunology.
[109] D. Carrasco,et al. Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.
[110] R. Bravo,et al. Functional Redundancy of the Nuclear Factor k B Inhibitors I k B a and I k B b , 1998 .
[111] S. Ley,et al. Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .
[112] D. Brenner,et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.
[113] N. Tarantino,et al. In Vivo Inhibition of NF-κB in T-Lineage Cells Leads to a Dramatic Decrease in Cell Proliferation and Cytokine Production and to Increased Cell Apoptosis in Response to Mitogenic Stimuli, But Not to Abnormal Thymopoiesis , 1999, The Journal of Immunology.
[114] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.
[115] E. Oltz,et al. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. , 1999, Molecular immunology.
[116] J. Leiden,et al. NF-κB Is Required for the Positive Selection of CD8+ Thymocytes1 , 2000, The Journal of Immunology.
[117] A. Israël,et al. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.
[118] Rinat Abramovitch,et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.
[119] M. Karin,et al. IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .
[120] E. J. Green,et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.
[121] M. Karin,et al. IKKβ Is Required for Peripheral B Cell Survival and Proliferation1 , 2003, The Journal of Immunology.
[122] M. Leist,et al. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.
[123] F. Yull,et al. Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function. , 2000, Journal of immunology.
[124] Tak W. Mak,et al. The role of nuclear factor-κB essential modulator (NEMO) in B cell development and survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[125] N. Perkins. Oncogenes, tumor suppressors and p52 NF-kappaB. , 2003, Oncogene.
[126] K. Rajewsky,et al. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance , 2004 .
[127] David S. Park,et al. Constitutive nuclear factor-kappa B activity is required for central neuron survival. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[128] M. Matsumoto,et al. Abnormal Immune Function of Hemopoietic Cells from Alymphoplasia (aly) Mice, a Natural Strain with Mutant NF-κB-Inducing Kinase1 , 2000, The Journal of Immunology.
[129] C. Galanos,et al. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.
[130] Klaus Rajewsky,et al. NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .
[131] W. Birchmeier,et al. Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. , 2001, Development.
[132] D. Goeddel,et al. Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .
[133] Hideaki Ishikawa,et al. Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-κB1) but Expressing p50 , 1998, The Journal of experimental medicine.
[134] B. Dörken,et al. Stroma-Mediated Dysregulation of Myelopoiesis in Mice Lacking IκBα , 2005 .
[135] A. Israël,et al. IκBα/IκBε deficiency reveals that a critical NF-κB dosage is required for lymphocyte survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[136] A. Israël,et al. IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival. , 2003, Proceedings of the National Academy of Sciences of the United States of America.